- Who can participate: Adults aged 18 to 65 with a diagnosis of Type 2 Diabetes may be eligible to participate. Key eligibility factors include stable medication regimen and no significant health issues aside from diabetes.
- Study details: Participants will receive either the investigational medication or a placebo. They will be required to attend scheduled clinic visits for monitoring and assessments, which include blood tests and health evaluations.